Altogether, activation of EDA-A2/EDA2R signaling suppresses colonic crypt cell proliferation in DSS-treated miR-494−/− mice, an effect mediated via abrogation of the Wnt3a/β-catenin/c-Myc signaling in IBD. Here, WNT3A is linked to inflammatory bowel disease.